Dow Pharma Solutions a business unit of DowDuPont Speciality Division is proud to be part of the 10th Conference of the European Pediatric Formulation Initiative.
Forming part of the conference a pharmaceutical excipients working group will host a workshop which aims to address safety issues and problems associated with the excipients likely to be used in pediatric formulations. The group is intended to drive forward the development of the methodological approaches for conducting a high-level scientific literature review to retrieve and evaluate the safety and toxicity information of excipients for children. The group will determine a prioritization process for selected excipients based on: the strength of the literature evidence; broad applicability across the pharmaceutical industry; and potential for endorsement in Europe, US and worldwide following regulatory screening.
As part of this workshop Dr. Mohammad Qadir, TS&Dm Scientist, will present a poster entitled: “Tablet Compression Optimization and Excipient Polymer Design for High-Productivity Mini-Tab Production”.
DuPont will have experts present throughout the event, so please do take this opportunity to connect with us.
Find out more about the event here.